BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Entrada Therapeutics Reports Third Quarter 2023 Financial Results

  Entrada Therapeutics, Inc. reported financial results for the third quarter ending September 30, 2023, and highlighted recent business updates.

  November 7, 2023

   · 

  10 min read
• Business

  Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results

  Praxis Precision Medicines, Inc. provided a corporate update and reported financial results for the third quarter 2023.

  November 7, 2023

   · 

  9 min read
• Business

  Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update

  Rhythm Pharmaceuticals, Inc. reported financial results and provided a business update for the third quarter ended September 30, 2023.

  November 7, 2023

   · 

  24 min read
• Genetown

  Walden Biosciences to Host Virtual Event on November 14, 2023 “Transforming the Treatment Landscape of Chronic Kidney Disease”

  Walden Biosciences, Inc. announced that management will host a virtual event titled, “Transforming the Treatment Landscape of Chronic Kidney Disease,” on November 14, 2023 from 11:00 a.m. to 12:30 p.m. EST.

  November 7, 2023

   · 

  2 min read
• Business

  Altimmune Announces Third Quarter 2023 Financial Results and Provides a Business Update

  Altimmune, Inc. announced financial results for the three months ended September 30, 2023, and provided a business update.

  November 7, 2023

   · 

  10 min read
• Business

  Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results

  Zevra Therapeutics, Inc., a rare disease therapeutics company, provided corporate updates and reported its financial results for the quarter ended September 30, 2023.

  November 7, 2023

   · 

  23 min read
• Business

  Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

  Bioventus Inc., a global leader in innovations for active healing, reported financial results for the three and nine months ended September 30, 2023.

  November 7, 2023

   · 

  34 min read
• Pharm Country

  EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613

  EOM Pharmaceutical Holdings, Inc. provides an update on its clinical program for its lead drug candidate EOM613.

  November 7, 2023

   · 

  6 min read
• Business

  Compugen Reports Third Quarter 2023 Results

  Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced financial results for the third quarter ended September 30, 2023, and provided a corporate update.

  November 7, 2023

   · 

  13 min read
• ChitogenX Launches Burn and Skin Repair Development Program

  ChitogenX Inc. announced that it has launched a new development program targeting significant unmet medical needs in the burn and skin repair market, currently valued at US $19B and growing at 5% + CAGR through 2032.

  November 7, 2023

   · 

  3 min read